Paris Court's Ruling on Functionality Impact is Minimal for Angelalign's Customers

Minimal Impact of Paris Court Ruling on Angelalign's Clients

On October 18, 2026, Angelalign Technology Inc. released a statement following a ruling by the local division of the Unified Patent Court in Paris regarding its Torque Ridges feature. This decision declared that the feature infringes on a patent held by Align Technology, affecting its availability in Europe.

Despite the ruling, Angelalign, which specializes in innovative orthodontic clear aligner technology, reassured its customers that the change will have minimal repercussions. The company has proactively replaced the Torque Ridges feature with an upgraded technology known as Pressure Points, which was launched in Europe in September 2026. This new feature aims to enhance orthodontic torque control, reflecting Angelalign's commitment to continuous innovation.

The Transition from Torque Ridges to Pressure Points

According to Angelalign, the transition to Pressure Points means that orthodontists in Europe can continue to deliver high-quality care to their patients without disruption. While the ruling impacts the Torque Ridges functionality, it does not affect Angelalign's offerings in other locations, including Spain, the UK, Asia, and America, where the company is still active and serving clients with the new technology.

Xavier Cherbavaz, Angelalign's General Manager and Vice President for Europe, Africa, and the Middle East, emphasized that the company’s top priority remains ensuring orthodontists can provide excellent patient care. With the removal of Torque Ridges in Europe, orthodontists will utilize Pressure Points while receiving continuous clinical and technical support from Angelalign.

Legal Context and Response

The ruling made by the court has led Angelalign to respect the judicial decision, although the company is currently reviewing the ruling's implications and weighing its options. Richard Hirschland, Senior Vice President and Commercial Director at Angelalign, expressed the company's determination to examine all legal recourse available. He explained that while the company takes intellectual property rights seriously, Angelalign is committed to fostering innovation and improving its products despite legal challenges posed by competitors.

Angelalign is also dedicated to adhering to patent laws, ensuring no violations occur in its operations. This commitment to legal compliance is part of their broader strategy to provide reliable solutions for orthodontists. Furthermore, the swift transition to Pressure Points demonstrates their proactive approach in addressing clinical challenges while enhancing the user experience for dental professionals.

Commitment to Innovation

Founded in 2003 and publicly traded since 2021, Angelalign Technology has continuously offered transparent aligner solutions to health professionals and patients in over 60 countries. With more than two million treated cases and a market capitalization of around $2 billion, Angelalign emphasizes clinical innovation and robust support for orthodontists aiming for exceptional treatment outcomes.

Moving forward, the company is poised to continue developing new solutions that effectively address the evolving challenges orthodontists face globally. Angelalign's long-term vision is to provide dependable products and experiences for both providers and their patients, ensuring that orthodontic practitioners have access to cutting-edge technologies and support.

For more detailed information about Angelalign’s products and commitment to innovation, visit Angelalign's official website.